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Objectives: To determine the prevalence of and associated factors for glucose intolerance 
among antenatal clients at Kenyatta national hospital at 24-36 weeks of gestation.
Design: cross-sectional analytical study.
Setting: Kenyatta national hospital antenatal clinic.
Subjects: one hundred and two (102) antenatal mothers at a gestational age of 24-36 
weeks were recruited into the study and underwent a 100g oral glucose Tolerance 
Test (ogTT) after consenting to participate in the study.  
Results: from the study 37(36%) had glucose intolerance while 65 (64%) had normal 
glucose tolerance. among clients with glucose intolerance, 16.7% met the diagnostic 
criteria for gestational diabetes, 3.9% had impaired glucose tolerance and 15.7% had 
impaired fasting glycaemia. of the clients with normal glucose tolerance 22.5% displayed 
flat curves. Factors significantly associated with glucose intolerance were: BMI > 25; 
p-value 0.036: or 0.37 ci (1.06-6.90), history of and treatment for sub-fertility p-value 
0.002: OR 8.69 CI (1.74-43.50) and family history of hypertension; p-value 0.037: OR 
2.66 ci (1.04-6.78).
Conclusion: The prevalence of glucose intolerance was 36%. This is much higher than 
the 5% previously reported. There is need to screen pregnant women for glucose 
intolerance to prevent the complications usually associated with it.
inTroducTion
Glucose intolerance is defined as a state of impaired 
glucose homeostasis characterised by hyperglycaemia, 
abnormalities of lipid and protein metabolism due to 
the defect in insulin secretion and action (1, 2). There is 
an increase in trends in the developing nations of cases 
of diabetes mellitus whose management is expensive 
whereas in these countries health resources are mostly 
spent on curative services on communicable diseases. 
Currently it is only diabetes mellitus which is the only 
non-communicable disease with a special United 
Nations Declaration, with 14 November declared 
as the world’s diabetic day (3). Gestational diabetes 
is estimated to complicate 1-14% of all pregnancies 
with mild degrees of glucose intolerance being 
even higher (4-7). It is associated with increased 
maternal morbidity, foetal/neonatal morbidity and 
mortality with an increased risk of future micro 
and macrovascular complications (8-14). These are 
potentially preventable through early diagnosis and 
risk modification (15-17). The hormonal changes in 
pregnancy leads to changes in glucose metabolism 
which may manifest as various degrees of glucose 
intolerance in individuals with inherited or acquired 
defects in glucose regulation.These are caused by 
insulin deficiency, receptor abnormality or post 
receptor abnormality resulting in reduced glucose 
entry into cells with stimulation of lipid and protein 
metabolism (18, 19). They are classified depending on 
etiology and clinical presentation. Diabetes Mellitus 
type 1 and 2 gestational diabetes. Impaired Glucose 
Tolerance (IGT) is the state of impaired glucose 
regulation characterised by hyperglycaemia with 
blood sugar levels below the threshold required 
to diagnose Diabetes Mellitus Impaired Fasting 
Glycaemia (19). There is very limited information on 
the prevalence of glucose intolerance in pregnancy 
in the Kenyan population; Githaiga in Kenyatta 
National Hospital in 1991 reported an incidence rate 
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of 0.15% (20) a previous study gave a prevalence rate 
estimate of 7%(21).
 Prevalence rates for gestational diabetes alone 
in the world range from 1-14 % depending on the 
race, ethnic group and screening criteria used (4 - 6, 
22). With little information currently available on 
the prevalence of glucose intolerance in pregnancy 
in Kenya, this study is aimed at providing this 
information.
 The objective of the study was to determine the 
prevalence of glucose intolerance among antenatal 
clinic attendants at 24 to 36 weeks of gestation at 
Kenyatta National Hospital. 
maTerials and meThods
Study design: This was a cross sectional analytical 
study, 102 antenatal mothers at 24-36 weeks of 
gestation were recruited. 
Study site:  The study was carried out at the antenatal 
clinic, Kenyatta National Hospital.The clinic handles 
300 pregnant mothers weekly.
Study population: This consisted of expectant mothers 
at 24-36 weeks of gestation who were attending the 
antenatal clinic during the study period, fulfilled the 
inclusion criteria and consented to the study. 
Inclusion criteria:  Clients attending the antenatal clinic 
during the study period at   24-36 weeks of gestational 
without pre-gestational or gestational diabetes and 
provided informed consent. 
Exclusion criteria: Clients who had pre-gestational 
diabetes mellitus, those already diagnosed with 
glucose intolerance in the current pregnancy or in 
previous pregnancy, clients who did not consent and 
clients on medications for chronic treatment.
Sampling frame: This consisted of antenatal mothers 
attending the antenatal clinic between November 15th 
2008 and 15th April 2009.
The sample size was calculated using the formula for 
prevalence rates: the prevalence used was 7% being 
the average of the estimated total prevalence of GDM 
of 1-14 %(4-7) giving a sample size of 100.
Sampling method: Systematic sampling of every 
4thclient reporting to the observation room of the 
antenatal clinic and met the study criteria was done. 
Only five clients were recruited per day due to the 
limitation by the laboratory capacity.
Research personnel: Three research assistants were 
recruited consisting of a trained nursing officer 
working in the antenatal clinic and two laboratory 
technicians working within the biochemistry 
laboratory who administered OGTT. 
Laboratory method: A fasting capillary blood sample 
was taken 30 minutes after arrival in the laboratory 
(finger puncture after swabbing the finger with 
methylated spirit) and tested for sugars. A 300 
millilitre solution containing 100g of glucose was then 
administered orally over five minutes and capillary 
blood drawn and tested for sugars hourly for three 
hours. During this period the vital signs of the clients 
were taken every 15 minutes. Clients were advised 
to minimise physical activity during the test period. 
The blood drop obtained after a needle prick was 
analysed using reflectance meters with accompanying 
strips. The clients were then provided with snacks at 
the completion of the study. 
Quality control: The Hemocue Glucometer used 
was run through a control strip whenever any set 
of glucose strips was opened and then subjected 
to weekly calibration. The glucose testing was 
periodically supervised by a qualified pathologist.
Standards were maintained in accordance with preset 
standards. Interpretation of the test results was done 
according to the Carpenter Couston criterion which 
is recommended by the ADA (29, 37 - 39). 
Normal values: Fasting blood sugar < 5.3mmol/dl, one 
hour post prandial <10.0mmol/dl,  two hour post 
prandial <8.6mmol/dl,  three hour post prandial < 
7.8 mmol/dl. 
Abnormal values: Any two or more values equal to or 
greater than the above or a fasting blood glucose > 
7.0mmol/dl were classified as GDM. Presence of one 
abnormal one, two or three hour value was classified 
as impaired glucose tolerance. A fasting blood sugar 
more than 5.3mmol/dl but less than, 7.0 mmol/dl 
was classified as Impaired Fasting Glycaemia (29). 
A test result where the peak glucose level was less 
than 7.0 mmo/dl without the normal peak at 30-60 
minutes was classified as flat glucose tolerance curve. 
For analysis, normal glucose tolerance(all three 
values within normal limits)and Flat curves with 
fasting glucose below 5.3 mmol/dl were analysed 
as normal glucose tolerance while GDM, impaired 
fasting glycaemia and impaired glucose tolerance as 
`Glucose intolerance’.
Ethical issues: The study was approved by the Kenyatta 
National Hospital/University of Nairobi Ethics and 
Research committee (KNH/UON ERC). There was no 
coercion or financial inducements to the participants. 
The clients found to be have gestational diabetes(GD) 
were informed and were then managed by both the 
Diabetologist and the Obstetricians. Those who had 
no GD were informed and continued on the routine 
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antenatal care in the antenatal clinic.
Data management: Data were collected using pre-
tested questionnaires and the laboratory test results 
were recorded on the standard hospital forms. These 
were checked for completeness before data entry. The 
analysis was done using SPSS version 15.
resulTs
The study period was six months, 102 clients were 
recruited into the study who underwent a three hour 
100g OGTT as the methodology above.  The results 
are presented below.
Table 1
The study population by socio-demographic characteristics (N=102)
Socio-demographic Characteristic Frequency  Percentage
 n=102 (%)
Age 
< 25 years 21  20.6
≥ 25 years  81  79.4
Marital status
Single  11  89
Married 89 11
Residence in the past 10 years 
Rural  13  12.7
Urban/rural then urban  89  87.3
Level of education
Primary and below 13  13.0
Secondary and above  87  87.0
Employment status
Currently employed  58 56.9
Self  30  51.7
Salaried  28  48.3
Unemployed  44  43.1
Income per month (ksh)
< 15,000 36  62.1
15,000-30,000  22  37.9
Pre-pregnancy BMI
≥ 25 36   35.3
< 25 41  40.2
Unknown 25  24.2
 Seventy nine percent of the participants were 
aged 25 years and above with a mean age of 29.3 
years.Eleven percent were single while eighty nine 
were married. Most had resided in urban centre 
within the past ten years. Eighty seven had received 
at least secondary education.
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Table 2
Obstetrics and familial characteristics
1. Obstetric characteristic  Frequency  (%)
 Gravidity (102)
  Primigravid 36  35.3
  Multigravid 66 64.7
 Glycosuria in current pregnancy 4 3.9
 Polyhydramnous in current/past pregnancy 1 1
 Pregnancy larger  than dates  15  14.7
 Previous neonatal weight ≥ 4000g 8 7.9
 Previous pregnancy wastage 16 15.6
 Hypertension in previous pregnancy 11 10.8
 History of Gestational diabetes 1 1
 History of infertility 10 9.8
 Medical treatment for sub-fertility 6 5.9
2. Familial characteristics  Frequency  (%)
 Family Hx of diabetes 20 19.6
 Family Hx of hypertension 24 23.5
 Family Hx of sudden death 6 5.9
 Family Hx of CVA 9 8.8
 Family member with obesity 4 3.9
 Only one client had been diagnosed with glucose 
intolerance in previous pregnancy which subsided after 
delivery. Fifteen point six percent of the participants reported 
an adverse pregnancy outcome; an abortion, stillbirth or 
preterm delivery. Seven point eight percent had had a 
previous delivery to a neonate ≥ 4000g, nine reported having 
sub-fertility, out of which six had received treatment.The 
mean birth weights for previous deliveries were 3.19 kg (SD 
0.69) for first; 3.22 kg (SD 0.73) for second and 3.86 kg (SD 
0.30) for third deliveries. Nineteen percent of participants 
gave a positive family history of diabetes while 23% had 
a family history of hypertension. Few reported family 
history of other vascular disease.
Mean blood glucose values: The mean blood glucose 
values were 4.82mmol/dl fasting (1.00), one hour 
post prandial of 7.59mmol/dl (1.55), two hour post 
prandial of 6.68 mmol/dl (1.35) and three hour post 
prandial of 6.15 mmol/dl (1.29) with the ranges of 
3.1-12.1mmol/l, 3.4-11.9 mmol/l, 4.0-9.8 mmol/l and 
3.8-12.2 mmol/dl for fasting, one, two and three hour 
post prandial respectively.
figure 1
 Mean blood glucose values of the participants
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Glucose tolerance patterns: Out of the 102 participants, 
42 (41.2%) had normal glucose tolerance, 23 (22.5%) 
met the diagnostic criteria of flat curves, while 19.6 
had mild degrees of glucose intolerance (one abnormal 
value). Sixteen point seven met the diagnostic criteria 
of gestational diabetes mellitus (Table 3).
Glucose tolerance pattern of the study subjects: Overall, 
the total number of clients with normal glucose 
tolerance was 65(63.7%) that is normal plus flat curves 
while 37 (36.3%) had glucose intolerance (impaired 
fasting glycaemia, impaired glucose tolerance and 
Gestational Diabetes Mellitus) as depicted in figure 
2. Of the clients with glucose intolerance, 48 % were 
at a gestational age of 28 weeks and below while 52 % 
were more than 28 weeks gestational age (figure 2).
figure 2
Glucose tolerance patterns of study subjects
Table 3 
Obstetric characteristics and glucose intolerance.
  Glucose intolerance O.R(95% CI) P-Value 
 Yes (%)         No (%)
Gravidity
                 Primigravid  14(39.0)  22(61.0)  1.19(0.51-2.76)  0.69
                 Multigravid  23(34.8) 43(65.2) 
Glucosuria in current 
pregnancy 3(75.0) 1(25.0)  5.65(0.57-56.39)  0.10 
Excess liquor in this 
pregnancy 1(100.0) 0(0) - 0.18
Current pregnancy larger 
than dates 6(40.0) 9(60.0) 1.21(0.39-3.71) 0.75
Neonatal weight ≥ 4000g 5(62.5) 3(37.5) 3.2(0.73-14.38) 0.11
Neonatal NBU admission 2(22.2) 7(77.8) 0.47(0.09-2.41) 0.36
Previous pregnancy loss 6(37.5) 10(62.5) 0.58(0.23-1.48) 0.25
Hypertension in pregnancy 4(36.4) 7(63.6) 1.00(0.27-3.69 1.0
Hx of gestational D.M 1(100.0) 0(0) - 0.18
Difficulty in conception 8(80.0) 2(20.0) 8.69(1.74-43.50) 0.002
Treatment  for sub-fertility 5(83.3) 1(16.7) 10(1.12-89.22) 0.013
 No association was demonstrated between 
parity, larger for gestational age pregnancy, prior 
pregnancy loss, hypertension, polyhydramnous, 
Glycosuria and neonatal NBU admission and glucose 
intolerance. Positive history of difficulty in conception 
and treatment for infertility were associated with 
statistically significant risk of abnormal glucose 
tolerance test (Table 3).
discussion
The study comprised of 102 participants with a mean 
age of 29.3 years and a median age of 28.0 years (SD 
5.40). Seventy nine percent of clients in the study were 
above 25 years. Githaiga in 1991 demonstrated that 
75 % of mothers with diabetes mellitus were above 
25 years (20) while in this study 41% of mothers with 
glucose intolerance were above 25 years. Thirty 
five percent of these had glucose intolerance were 
multiparous a figure different from Githaiga et al 
where 91 % with abnormal glucose intolerance were 
multiparous. Other similar studies have associated 
glucose intolerance to high parity (23,24). In the 
study, the mean birth weights for clients with glucose 
intolerance was similar to the study population with 
regard to the first delivery but high for the second 
and third deliveries thus; 3.1, 3.4 and 3.9 kg for first, 
second and third deliveries respectively
 Glucose intolerance is associated with higher 
birth weight due to glucose deposition and increased 
adiposity (10, 20). Foetal macrosomia is estimated to 
complicate one in every word pregnant mothers with 
glucose intolerance (11). Previous findings in KNH 
have found a prevalence of foetal macrosomia in 
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7.8 % of mothers gave a history of previous infant 
birth weight > 4000g. Sixty three percent of them 
had glucose intolerance though the association was 
not statistically significant. This is higher than the 
findings of the Nairobi birth survey IV which showed 
an incidence rate of foetal macrosomia of 4.2 % in the 
general population and 1.3 % in teenagers (25). 
 The prevalence of familial risk factors for 
microvascular disease ranged from 19% for diabetes 
which is five times higher than our estimated 
national prevalence of type 2 diabetes in the general 
population, which is estimated at 3.3 %. This was not 
statistically significant, P-value 0.05: OR 2.66(1.4-6.78), 
perhaps due to the small sample size. Twenty four 
percent reported a family history of hypertension 
which was statistically significant, P-value 0.037; OR 
2.66 (1.04-6.78); an alarming figure considering that 
this was a non-selected low risk population.Only a 
small proportion reported a family history of obesity 
(3.9%) which is unreliable since it is a subjective 
assessment though it was not a statistically significant 
association. 
 The results showed a prevalence of glucose 
intolerance of 36% with gestational diabetes 
comprising 16.7%, mild degrees of glucose intolerance 
was 19.6% while flat curves comprised 22.5%. This 
depicts high rates of glucose intolerance as compared 
to previous estimations of less than 1% incidence of 
gestational diabetes by Githaiga in 1986 ( 23). Rates 
of 7 % for East Africa have been estimated in the year 
2002 though this was based on fasting blood glucose 
(26). This is in line with the current observations 
that have demonstrated similar increase especially 
in third world Nations (1,2). However, most studies 
have restricted screening to a gestation of 24-28 
weeks hence this could lend support to the benefit 
of extending the screening time to beyond 28 weeks 
to increase detection rates (27) as 52 % of mothers 
with glucose intolerance in this study were between 
29 to 36 weeks. The prevalence of flat curves which 
is thought to be due to intestinal stasis with reduced 
absorption is slightly more (22 %) than that observed 
in previous studies by Thuo in 1980 which showed 
figures of 18 % (28).
 The ADA recommends a two stage screening 
approach starting with a one hour 50g glucose 
challenge followed by a three hour OGTT in 
populations with low prevalence rates. In populations 
with rates more than 2%, a one step screening 
approach using an OGTT is recommended (13). Our 
antenatal clients meet the criteria for routine three 
hour OGTT beginning at 24 weeks gestation. 
 Wagaarachchi and others have demonstrated 
lower maternal age to be associated with a 50% 
lower incidence of GDM as compared to mothers of 
advanced age (29). Among our antenatal population, 
mothers aged less than 25 years had a three fold lower 
risk of glucose intolerance compared to mothers aged 
over 25 years, 19% versus 41% respectively. Only 
28% of clients who earned less than Ksh15,000 had 
glucose intolerance as compared to 50 % with income 
more than Ksh 15,000; an indicator of  the effect of 
socio-economic status though the difference was 
not statistically significant. There was no difference 
in residence in the past ten years and employment 
status with glucose intolerance contrary to expectation 
as urban residence or migration from rural to urban 
centre has consistently been associated with a higher 
risk of glucose intolerance (2,29). A pre-pregnancy 
BMI > 25 was positively associated with glucose 
intolerance; a similar finding to other studies (17). 
This could be a risk factor per se but could also 
be influenced by maternal age, parity and socio-
economic status. Of note is that 35% of the study 
population had a pre-pregnancy BMI of > 25, a figure 
far above the estimation given by the 2003 Kenya 
Demographic and Health Survey of  23% (24).    Only 
one mother with glucose intolerance had a history 
of glucose intolerance in prior pregnancy which had 
subsided post delivery. This low prevalence could be 
due to lack of routine screening among our antenatal 
population hence most asymptomatic mothers are 
not diagnosed. 
 History of infertility was associated with glucose 
intolerance, P-value 0.002; OR 8.69 (1.74-43.50).The 
causes and treatment modalities for the infertility were 
not documented. Glucose intolerance is a preventable 
illness that is associated with high morbidity and 
mortality due to associated macrovascular and 
microvascular complications including blindness, 
coronary artery disease, diabetic feet and neuropathy. 
From this study, it is obvious that we are at a high risk 
like most other third world nations (1,2). The cost of 
screening is only about three dollars per person. This 
should be a wakeup call to screen mothers to avoid 
complications from diabetes in pregnancy. 
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